Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating the efficacy and safety of controlled-release Huperzine A tablets in patients with Alzheimer's-type dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Huperzine A (Huperzine A)

Snippet

Sponsor: Wanbangde Pharmaceutical Group Co., LTD | Conditions: Alzheimer Dementia | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING